Precision medicine is part of the logical evolution of contemporary evidence-based medicine
that seeks to reduce errors and optimize outcomes when making medical decisions and …

Background Research using data-driven cluster analysis has proposed five subgroups of
diabetes with differences in diabetes progression and risk of complications. We aimed to …

Aims/hypothesis Classically, type 1 diabetes is thought to proceed to absolute insulin deficiency.
Recently developed ultrasensitive assays capable of detecting C-peptide under 5 pmol/…

Recent epidemiological data have shown that more than half of all new cases of type 1
diabetes occur in adults. Key genetic, immune, and metabolic differences exist between adult- …

OBJECTIVE To assess whether clinical characteristics and simple biomarkers of β-cell failure
are associated with individual variation in glycemic response to GLP-1 receptor agonist (…

Precision medicine aims to treat an individual based on their clinical characteristics. A
differential drug response, critical to using these features for therapy selection, has never been …

Latent autoimmune diabetes of adults (LADA) is typically defined as a new diabetes diagnosis
after 35 years of age, presenting with clinical features of type 2 diabetes, in whom a type 1 …

Methods We assessed the characteristics of type 1 diabetes defined by rapid insulin requirement
(within 3 years of diagnosis) and severe endogenous insulin deficiency (non-fasting C-…

Background In the treatment of type 2 diabetes, GLP-1 receptor agonists lower blood glucose
concentrations, body weight, and have cardiovascular benefits. The efficacy and side …

OBJECTIVE The choice of therapy for type 2 diabetes after metformin is guided by overall
estimates of glycemic response and side effects seen in large cohorts. A stratified approach to …